Vendor, Rockville, MD
Cellphire, Inc.
UEI F42VPQJ8LJL4, CAGE 48GV8
1 award and $48,234,629 obligated between March 8, 2024 and April 14, 2026, 100% under full and open competition, against 3.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $48,234,629 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W81XWH20C0030Definitive Contract, March 8, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | Army Med Res Acq ActivityDefense Health Agency | Phase II Clinical TrialNAICS 541715, PSC AN94 | $48,234,629 |
- Places of performance
- Maryland
- Product and service codes
- AN94 N – Health R&D Services
- Transactions
- 8 across 1 awards